Jorma Toppari
MD, PhD
jortop@utu.fi +358 29 450 2826 +358 40 180 2600 Kiinamyllynkatu 10 Turku Työhuone: C5 floor ORCID-tunniste: https://orcid.org/0000-0003-2228-334X |
Lastenendokrinologia; lisääntymisterveys; hormonaaliset haitta-aineet; kives; tyypin 1 diabetes
Professor Jorma Toppari (H-index 68) is an international expert in environmental endocrine disruption, male reproduction and type 1 diabetes. He is a principal investigator in a NIH-funded cohort study The Environmental Determinants of Diabetes in the Young (TEDDY) and in the Finnish Type 1 Diabetes Prediction and Prevention Study (DIPP). He is leading a joint Finnish-Danish birth cohort study exploring the genetic and environmental aspects of human reproduction.
The aim of our research is to identify risk factors of reproductive health and type 1 diabetes (T1D) to make risk management possible and prevent health problems. We are performing a comprehensive reproductive health study for 19-year-old men that we have followed up prospectively from pregnancy. We focus now our studies on sperm epigenome. We are studying the role of retinoblastoma protein (Rb) and E2F3 transcription factors in gonadal development and whether endocrine disruptors affect reproductive health. In the Finnish type 1 Diabetes Prediction and Prevention (DIPP) study and in The Environmental Determinants of Diabetes in the Young (TEDDY) study we are exploring the early determinants of T1D in large child cohorts with increased genetic risk.
Basic and clinical endocrinology, particularly pediatric and reproductive endocrinology, endocrine disruption, reproductive toxicology
- Effect of Previous Alkylating Agent Exposure on Follicle Numbers in Cryopreserved Prepubertal and Young Adult Ovarian Tissue after Long-Term Xenografting (2022)
- Cancers
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Endocrine and Local Regulation of Testicular Hormone and Sperm Production (2022) Oxford Textbook of Endocrinology and Diabetes Huhtaniemi Ilpo, Toppari Jorma
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Environmental Influences and Male Reproductive Health (2022) Oxford Textbook of Endocrinology and Diabetes Toppari Jorma
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely (2022)
- Diabetes Technology and Therapeutics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Genetics of cryptorchidism and testicular regression (2022)
- Best Practice and Research: Clinical Endocrinology and Metabolism
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä) - Goodbye International Journal of Andrology, welcome Andrology! (2022)
- Andrology
(O2 Muu julkaisu ) - HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children (2022)
- Pediatric Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Health-related quality of life in boys with constitutional delay of growth and puberty (2022)
- Frontiers in Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA (2022)
- Clinical diabetes and endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study (2022)
- Diabetes Care
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - History of the European Academy of Andrology (2022)
- Andrology
(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä ) - INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6-month treatment with incretin-based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double-blind, randomised controlled trials (INVESTDIA) (2022)
- Diabetic Medicine
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes (2022)
- Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children (2022)
- Diabetes Care
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Maternal energy-adjusted fatty acid intake during pregnancy and the development of cows' milk allergy in the offspring (2022)
- British Journal of Nutrition
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Non-HLA Gene Polymorphisms in the Pathogenesis of Type 1 Diabetes: Phase and Endotype Specific Effects (2022)
- Frontiers in Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Novel Expression of Zona Pellucida 3 Protein in Normal Testis; Potential Functional Implications (2022)
- Molecular and Cellular Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Onset and progression of puberty in Klinefelter syndrome (2022)
- Clinical Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Permutation-based significance analysis reduces the type 1 error rate in bisulfite sequencing data analysis of human umbilical cord blood samples (2022)
- Epigenetics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study (2022)
- Diabetes Care
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )